🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ablation Versus Non-ablation Strategies for Non-puerperal Mastitis: A Prospective Real-world Registry Study

Recruitingn/aAges 18 Years - anyFemaleSong Hongping
NCT07894614 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this prospective registry cohort study is to evaluate the efficacy and quality-of-life impact of ablation therapy in patients with non-puerperal mastitis. The main questions it aims to answer are: Does ablation therapy effectively control inflammation in patients with non-puerperal mastitis? Does ablation therapy lead to a superior quality of life compared to standard treatments? Researchers will compare patients receiving ablation therapy to those receiving oral medication or surgery to see if ablation provides better inflammatory control and improves patients' quality of life. Participants will undergo their assigned treatment (ablation, oral medication, or surgery) and be asked to complete regular follow-up visits and quality-of-life questionnaires over a long-term period.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients with non-puerperal mastitis confirmed by puncture or surgical pathology; 2. Age ≥ 18 years; 3. Voluntarily participate in this study and provide signed informed consent. Exclusion Criteria: 1. Pregnant or lactating women; 2. Concurrent breast cancer; 3. Severe hepatic or renal impairment (Definitions: Hepatic: ALT or AST \> 2.5 × ULN, or total bilirubin \> 2 × ULN, or Child-Pugh class B/C; Renal: eGFR \< 30 mL/min/1.73 m², or requiring dialysis).
💊

What it tests

  • Ablation
  • Observation
📍

Where

1 site
First Affiliated Hospital of Air Force Medical University
Xi'an, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy